Descriptive characteristics of prostate cancer cases (n = 75), subjects with BPH (n = 75), and controls subjects (n = 150)
Variable . | Cases . | BPH . | Controls . | P . | ||||
---|---|---|---|---|---|---|---|---|
Stage, n (%) | ||||||||
I | 8 (11) | |||||||
II | 45 (63) | |||||||
III | 13 (18) | |||||||
IV | 5 (7) | |||||||
Gleason grade, n (%) | ||||||||
Low (2, 3, 4) | 5 (7) | |||||||
Intermediate (5, 6, 7) | 48 (67) | |||||||
High (8, 9, 10) | 19 (26) | |||||||
PSA, ng/mL (median ± SE) | 11.6 ± 4.9*† | 5.9 ± 0.4 | 2.4 ± 0.3 | <0.01 | ||||
Testosterone, ng/dL (age-standardized median ± SE) | 314 ± 21 | 336 ± 21 | 298 ± 15 | 0.06 | ||||
Descriptive characteristics | ||||||||
Age, y (mean ± SD) | 74.0 ± 8.2* | 70.0 ± 6.5* | 64.0 ± 8.3 | <0.01 | ||||
BMI, kg/m2 (mean ± SD) | 26.2 ± 3.2* | 27.0 ± 3.5 | 27.6 ± 3.5 | 0.04 | ||||
Current smoker, n/N (%) | 20/66 (30) | 20/72 (28) | 44/120 (37) | 0.40 | ||||
Alcohol use, n/N (%) | 9/43 (21) | 17/61 (28) | 19/72 (26) | 0.71 | ||||
Metabolic (mean ± SD) | ||||||||
Adiponectin, ng/mL | 7.4 ± 5.0*† | 11.5 ± 6.4 | 12.8 ± 8.0 | 0.04 | ||||
Insulin, μIU/mL | 19.0 ± 27.0 | 13.1 ± 10.9 | 19.5 ± 23.3 | 0.15 | ||||
Glucose, mg/dL | 109 ± 40 | 105 ± 36 | 111 ± 40 | 0.60 | ||||
Lipid profile (mean ± SD) | ||||||||
Total cholesterol, mg/dL | 198 ± 43 | 197 ± 44 | 207 ± 45 | 0.35 | ||||
HDL cholesterol, mg/dL | 51 ± 14 | 52 ± 13 | 49 ± 14 | 0.31 | ||||
LDL cholesterol, mg/dL | 128 ± 39 | 124 ± 39 | 138 ± 42 | 0.11 | ||||
Triglycerides, mg/dL | 124 ± 78 | 132 ± 86 | 132 ± 55 | 0.30 |
Variable . | Cases . | BPH . | Controls . | P . | ||||
---|---|---|---|---|---|---|---|---|
Stage, n (%) | ||||||||
I | 8 (11) | |||||||
II | 45 (63) | |||||||
III | 13 (18) | |||||||
IV | 5 (7) | |||||||
Gleason grade, n (%) | ||||||||
Low (2, 3, 4) | 5 (7) | |||||||
Intermediate (5, 6, 7) | 48 (67) | |||||||
High (8, 9, 10) | 19 (26) | |||||||
PSA, ng/mL (median ± SE) | 11.6 ± 4.9*† | 5.9 ± 0.4 | 2.4 ± 0.3 | <0.01 | ||||
Testosterone, ng/dL (age-standardized median ± SE) | 314 ± 21 | 336 ± 21 | 298 ± 15 | 0.06 | ||||
Descriptive characteristics | ||||||||
Age, y (mean ± SD) | 74.0 ± 8.2* | 70.0 ± 6.5* | 64.0 ± 8.3 | <0.01 | ||||
BMI, kg/m2 (mean ± SD) | 26.2 ± 3.2* | 27.0 ± 3.5 | 27.6 ± 3.5 | 0.04 | ||||
Current smoker, n/N (%) | 20/66 (30) | 20/72 (28) | 44/120 (37) | 0.40 | ||||
Alcohol use, n/N (%) | 9/43 (21) | 17/61 (28) | 19/72 (26) | 0.71 | ||||
Metabolic (mean ± SD) | ||||||||
Adiponectin, ng/mL | 7.4 ± 5.0*† | 11.5 ± 6.4 | 12.8 ± 8.0 | 0.04 | ||||
Insulin, μIU/mL | 19.0 ± 27.0 | 13.1 ± 10.9 | 19.5 ± 23.3 | 0.15 | ||||
Glucose, mg/dL | 109 ± 40 | 105 ± 36 | 111 ± 40 | 0.60 | ||||
Lipid profile (mean ± SD) | ||||||||
Total cholesterol, mg/dL | 198 ± 43 | 197 ± 44 | 207 ± 45 | 0.35 | ||||
HDL cholesterol, mg/dL | 51 ± 14 | 52 ± 13 | 49 ± 14 | 0.31 | ||||
LDL cholesterol, mg/dL | 128 ± 39 | 124 ± 39 | 138 ± 42 | 0.11 | ||||
Triglycerides, mg/dL | 124 ± 78 | 132 ± 86 | 132 ± 55 | 0.30 |